Table 2 —

Metabolic parameters in the patients with type 2 diabetes grouped according to the treatment regimen

BI+SUBI+METBI+SU+METBI+MI
Sex (F/M)7/138/98/136/17
Age (years)61 ± 257 ± 256 ± 259 ± 2
BMI (kg/m2), 0 months28.7 ± 0.827.8 ± 0.928.6 ± 0.728.0 ± 1.1
Change in weight (kg), 12–0 months3.6 ± 0.7*2.1 ± 1.0*§3.7 ± 0.9*4.6 ± 1.1*
HbA1c (%), 0 months9.4 ± 0.39.9 ± 0.49.8 ± 0.49.8 ± 0.4
Change in HbA1c(%), 12–0 months−1.8 ± 0.3−2.6 ± 0.4−2.1 ± 0.3−1.9 ± 0.4
Serum triglyceride level (mmol/l), 0 months2.7 ± 0.62.3 ± 0.42.4 ± 0.22.7 ± 0.5
Change in serum triglyceride level (mmol/l), 12–0 months0.3 ± 0.10.5 ± 0.50.1 ± 0.10.1 ± 0.3
Serum sE-selectin level (ng/ml), 0 months72 ± 794 ± 1166 ± 780 ± 7
Serum sE-selectin level (ng/ml), 3 months65 ± 777 ± 11*60 ± 6*68 ± 5
Serum sE-selectin level (ng/ml), 12 months67 ± 8*78 ± 1062 ± 675 ± 7*
Serum sVCAM-1 level (ng/ml), 0 months363 (318–55)362 (272–508)356 (244–401)448 (280–596)
Serum VCAM-1 level (ng/ml), 3 months334 (259–399)*335 (236–429)312 (227–355)*447 (288–593)
Serum VCAM-1 level (ng/ml), 12 months353 (309–439)347 (308–509)315 (227–487)453 (315–593)
  • Data are n, means ± SEM, and median (range).

  • *

    * P < 0.05,

  • P < 0.01,

  • P < 0.001 for 3 or 12 vs. 0 months;

  • §

    § P < 0.05 versus other groups.